Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13527 | 766 | 33.1 | 56% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1052 | 9585 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AN 9 | Author keyword | 18 | 83% | 1% | 10 |
| 2 | SABARUBICIN | Author keyword | 15 | 88% | 1% | 7 |
| 3 | AN 7 | Author keyword | 8 | 100% | 1% | 5 |
| 4 | HL60 HUMAN PROMYELOCYTIC LEUKAEMIA | Author keyword | 6 | 71% | 1% | 5 |
| 5 | BARMINOMYCIN | Author keyword | 6 | 100% | 1% | 4 |
| 6 | FORMALDEHYDE ACTIVATION | Author keyword | 4 | 75% | 0% | 3 |
| 7 | DAUNOMYCIN | Author keyword | 3 | 14% | 3% | 23 |
| 8 | DOXOFORM | Author keyword | 3 | 100% | 0% | 3 |
| 9 | HISTONE H 1 | Author keyword | 2 | 67% | 0% | 2 |
| 10 | INTERSTRAND DNA CROSS LINKING | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AN 9 | 18 | 83% | 1% | 10 | Search AN+9 | Search AN+9 |
| 2 | SABARUBICIN | 15 | 88% | 1% | 7 | Search SABARUBICIN | Search SABARUBICIN |
| 3 | AN 7 | 8 | 100% | 1% | 5 | Search AN+7 | Search AN+7 |
| 4 | HL60 HUMAN PROMYELOCYTIC LEUKAEMIA | 6 | 71% | 1% | 5 | Search HL60+HUMAN+PROMYELOCYTIC+LEUKAEMIA | Search HL60+HUMAN+PROMYELOCYTIC+LEUKAEMIA |
| 5 | BARMINOMYCIN | 6 | 100% | 1% | 4 | Search BARMINOMYCIN | Search BARMINOMYCIN |
| 6 | FORMALDEHYDE ACTIVATION | 4 | 75% | 0% | 3 | Search FORMALDEHYDE+ACTIVATION | Search FORMALDEHYDE+ACTIVATION |
| 7 | DAUNOMYCIN | 3 | 14% | 3% | 23 | Search DAUNOMYCIN | Search DAUNOMYCIN |
| 8 | DOXOFORM | 3 | 100% | 0% | 3 | Search DOXOFORM | Search DOXOFORM |
| 9 | HISTONE H 1 | 2 | 67% | 0% | 2 | Search HISTONE+H+1 | Search HISTONE+H+1 |
| 10 | INTERSTRAND DNA CROSS LINKING | 2 | 67% | 0% | 2 | Search INTERSTRAND+DNA+CROSS+LINKING | Search INTERSTRAND+DNA+CROSS+LINKING |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DAUNOMYCIN | 26 | 18% | 17% | 130 |
| 2 | DCPGPTPAPCPG | 25 | 75% | 2% | 18 |
| 3 | DNA DRUG INTERACTIONS | 24 | 91% | 1% | 10 |
| 4 | ANTITUMOR DRUGS ADRIAMYCIN | 23 | 76% | 2% | 16 |
| 5 | 4 EPIADRIAMYCIN | 15 | 88% | 1% | 7 |
| 6 | PIVALOYLOXYMETHYL BUTYRATE | 12 | 53% | 2% | 16 |
| 7 | ANTIBIOTIC NOGALAMYCIN | 12 | 86% | 1% | 6 |
| 8 | DCGATCG | 12 | 86% | 1% | 6 |
| 9 | ANTITUMOR DRUG NOGALAMYCIN | 11 | 52% | 2% | 15 |
| 10 | DTGTACA | 11 | 100% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The power and potential of doxorubicin-DNA adducts | 2005 | 59 | 43 | 74% |
| Doxorubicin, DNA torsion, and chromatin dynamics | 2014 | 21 | 70 | 19% |
| The anthracycline antibiotics: antitumor drugs that alter chromatin structure | 2005 | 61 | 56 | 41% |
| Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells | 2001 | 32 | 45 | 58% |
| Structural studies of atom-specific anticancer drugs acting on DNA | 1999 | 158 | 175 | 17% |
| Anthracycline-formaidehyde conjugates and their targeted prodrugs | 2008 | 9 | 84 | 38% |
| Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent | 2015 | 0 | 92 | 54% |
| Exploiting anthracycline scaffold for designing DNA-targeting agents | 2001 | 18 | 28 | 43% |
| Drug-DNA Intercalation: From Discovery to the Molecular Mechanism | 2013 | 6 | 114 | 23% |
| Anthracyclines Still Prove Effective in Anticancer Therapy | 2013 | 7 | 38 | 18% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GAUHATI UNIV | 1 | 50% | 0.1% | 1 |
| 2 | MINIST EDUCSTATE SUR E PHYS | 1 | 50% | 0.1% | 1 |
| 3 | URA 311 | 1 | 50% | 0.1% | 1 |
| 4 | DSM DRECAM SPAM FRANCIS PERRIN | 0 | 33% | 0.1% | 1 |
| 5 | IST CRISTALOG | 0 | 33% | 0.1% | 1 |
| 6 | SANGAMO BIOSCI INC | 0 | 33% | 0.1% | 1 |
| 7 | TAU NANO SCI NANOTECHNOL | 0 | 33% | 0.1% | 1 |
| 8 | VITAMIN DRUGS | 0 | 33% | 0.1% | 1 |
| 9 | AREA ROME TOR VERGATA | 0 | 25% | 0.1% | 1 |
| 10 | CANC UKMOL PHARMACOL UNIT | 0 | 25% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000280427 | HETERO ASSOCIATION//HETEROASSOCIATION//ACTINOMYCINS |
| 2 | 0.0000276119 | METHOXYMORPHOLINO DOXORUBICIN//AD 198//METHOXYMORPHOLINYL DOXORUBICIN |
| 3 | 0.0000158794 | ANTHRACYCLINONE//NISHI OHNUMA//441 NISHI OHNUMA |
| 4 | 0.0000132979 | MENOGARIL//ACLARUBICIN//BIOSYNTHESIS AND PROCESSING |
| 5 | 0.0000123665 | PIROXANTRONE//MITOXANTRONE//PIXANTRONE |
| 6 | 0.0000120713 | CNRS UPR 285//PHOTOSCI PHOTON CHEM SCI TECHNOL//PERI ANNELATION |
| 7 | 0.0000107296 | PYRROLE IMIDAZOLE POLYAMIDE//DISTAMYCIN//MINOR GROOVE BINDERS |
| 8 | 0.0000107283 | PYRAZOLOACRIDINE//C 1311//IMIDAZOACRIDINONES |
| 9 | 0.0000102531 | ELSAMICIN A//CHARTREUSIN//ELSAMITRUCIN |
| 10 | 0.0000100338 | WARWICK ANALYT SCI//GELRED//DNA TOPOISOMERS |